Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Appl Clin Inform ; 2024 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-38848764

RESUMO

Pediatric healthcare has nuances not encountered in the delivery of adult medicine. In order to support these unique pediatric workflows, pediatric healthcare providers need to be involved in the development of pediatric focused health information systems. Unfortunately, not enough pediatrics are training in clinical informatics with only 31 clinical informatics fellows listing pediatrics as their primary specialty between 2016-2024. This is leading to a void in practicing pediatric clinical informaticists which is supported by the fact that only 320 clinical informaticists in the United States are pediatricians. Increased focus on cultivating the next generation of pediatric clinical informaticists is required. Contributing factors to the low attrition of pediatricians into clinical informatics training include the lack of clinical informatics specific content on the American Board of Pediatrics exam, and the small number of pediatric specific clinical informatics fellowship programs. Collaborative approaches are needed to ensure that enough pediatricians are trained in clinical informatics by 1) increasing trainee awareness of and interest in clinical informatics, 2) increasing pediatric trainees' knowledge of core clinical informatics concepts and 3) supporting the careers of future pediatric informaticists.

2.
Pediatr Blood Cancer ; 71(3): e30843, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38173090

RESUMO

OBJECTIVE: To design and evaluate a clinical decision support (CDS) module to improve guideline concordant venous thromboembolism (VTE) pharmacoprophylaxis prescribing for pediatric inpatients with COVID-19. MATERIALS AND METHODS: The proportion of patients who met our institutional clinical practice guideline's (CPG) criteria for VTE prophylaxis was compared to those who triggered a CDS alert, indicating the patient needed VTE prophylaxis, and to those who were prescribed prophylaxis pre and post the launch of a new VTE CDS module to support VTE pharmacoprophylaxis prescribing. The sensitivity, specificity, positive predictive value (PPV), negative predictive value, F1-score and accuracy of the tool were calculated for the pre- and post-intervention periods using the CPG recommendation as the gold standard. Accuracy was defined as the sum of the true positives and true negatives over the sum of the true positives, false positives, true negatives, and false negatives. Logistic regression was used to identify variables associated with correct thromboprophylaxis prescribing. RESULTS: A significant increase in the proportion of patients triggering a CDS alert occurred in the post-intervention period (44.3% vs. 6.9%, p < .001); however, no reciprocal increase in VTE prophylaxis prescribing was achieved (36.6% vs. 40.9%, p = .53). The updated CDS module had an improved sensitivity (55.0% vs. 13.3%), NPV (44.9% vs. 36.3%), F1-score (66.7% vs. 23.5%), and accuracy (62.5% vs. 42.0%), but an inferior specificity (78.6% vs. 100%) and PPV (84.6% vs. 100%). DISCUSSION: The updated CDS model had an improved accuracy and overall performance in correctly identifying patients requiring VTE prophylaxis. Despite an increase in correct patient identification by the CDS module, the proportion of patients receiving appropriate pharmacologic prophylaxis did not change. CONCLUSION: CDS tools to support correct VTE prophylaxis prescribing need ongoing refinement and validation to maximize clinical utility.


Assuntos
COVID-19 , Sistemas de Apoio a Decisões Clínicas , Tromboembolia Venosa , Humanos , Criança , Tromboembolia Venosa/tratamento farmacológico , Tromboembolia Venosa/etiologia , Tromboembolia Venosa/prevenção & controle , Pacientes Internados , Anticoagulantes/uso terapêutico , Fatores de Risco
3.
Blood Adv ; 7(13): 3225-3231, 2023 07 11.
Artigo em Inglês | MEDLINE | ID: mdl-36897253

RESUMO

Outcomes for children and adolescents with relapsed and refractory Hodgkin lymphoma (HL) are poor, with ∼50% of patients experiencing a subsequent relapse. The anti-CD30 antibody-drug conjugate brentuximab vedotin improved progression-free survival (PFS) when used as consolidation after autologous stem cell transplantation (ASCT) in adults with high-risk relapsed/refractory HL. Data on brentuximab vedotin as consolidative therapy after ASCT in pediatric patients with HL are extremely limited, with data of only 11 patients reported in the literature. We performed a retrospective analysis of 67 pediatric patients who received brentuximab vedotin as consolidation therapy after ASCT for the treatment of relapsed/refractory HL to describe the experience of this regimen in the pediatric population. This is the largest cohort reported to date. We found that brentuximab vedotin was well tolerated with a safety profile similar to that of adult patients. With a median follow-up of 37 months, the 3-year PFS was 85%. These data suggest a potential role for the use of brentuximab vedotin as consolidation therapy after ASCT for children with relapsed/refractory HL.


Assuntos
Transplante de Células-Tronco Hematopoéticas , Doença de Hodgkin , Adulto , Adolescente , Humanos , Criança , Brentuximab Vedotin/uso terapêutico , Doença de Hodgkin/tratamento farmacológico , Doença de Hodgkin/patologia , Transplante Autólogo , Estudos Retrospectivos
4.
J Pediatr Hematol Oncol ; 45(1): 41-43, 2023 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-36161881

RESUMO

Hereditary hemolytic anemias are a heterogenous group of disorders that include membranopathies, enzymopathies, and hemoglobinopathies. Genetic testing is helpful in the diagnostic workup when the clinical and laboratory workup is not conclusive. Here, we present a case of a 21-month-old female who was initially diagnosed with hereditary spherocytosis based on the presence of a variant of unknown significance in the SPTB gene. Further genetic workup revealed a homozygous glucose 6 phosphate isomerase mutation and the patient was ultimately diagnosed with glucose 6 phosphate isomerase deficiency.


Assuntos
Anemia Hemolítica Congênita , Anemia Hemolítica , Erros Inatos do Metabolismo , Esferocitose Hereditária , Feminino , Humanos , Lactente , Glucose-6-Fosfato Isomerase/genética , Anemia Hemolítica Congênita/diagnóstico , Anemia Hemolítica Congênita/genética , Anemia Hemolítica/diagnóstico , Anemia Hemolítica/genética , Esferocitose Hereditária/diagnóstico , Esferocitose Hereditária/genética , Erros de Diagnóstico
5.
Can Med Educ J ; 13(5): 111-113, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-36310903
6.
Pediatr Blood Cancer ; 69(8): e29638, 2022 08.
Artigo em Inglês | MEDLINE | ID: mdl-35293684

RESUMO

Progressive transformation of the germinal center (PTGC) is a common and underrecognized cause of pediatric lymphadenopathy. PTGC may be associated with numerous systemic medical conditions that require further workup and management, including malignancy, autoimmune conditions, lymphoproliferative conditions, immunodeficiency, and infection. Given the breadth and rarity of the associated conditions, workup should be tailored to the individual patient and occur in a tiered approach. Patients with PTGC require ongoing follow-up, given their long-term risk of malignancy and recurrent PTGC.


Assuntos
Doença de Hodgkin , Linfoma , Transformação Celular Neoplásica/patologia , Criança , Centro Germinativo/patologia , Doença de Hodgkin/patologia , Humanos , Linfoma/patologia
7.
Ochsner J ; 21(4): 352-357, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34984049

RESUMO

Background: Sickle cell disease (SCD) has a significant psychosocial impact on affected children. Summer camp has been shown to improve psychological and physical states for children with diabetes and cancer. However, opportunities to attend camp for children with SCD are limited, as many are from low-income families, and many camps are not equipped to care for children with medical complexities. To our knowledge, no literature evaluates how camp can positively affect emotional functioning, social functioning, self-esteem, and physical activity levels in children with SCD. Methods: Children with SCD attending a residential summer camp during 2019 were identified. Participants completed a modified version of the Pediatric Camp Outcome Measure, a validated 29-item questionnaire that evaluates self-esteem, emotional function, social function, and physical activity. Four additional questions related to SCD were included. Results: Nine campers enrolled in the study. Questionnaire results showed a total score of 113.7 (maximum score135, range 84-129), with a self-esteem subscale score of 22.1 (maximum score 25, range 20-25), an emotional subscale score of 32.1 (maximum score 40, range 25-39), a social subscale score of 38.9 (maximum score 45, range 24-45), and a physical activity subscale score of 20.6 (maximum score 25, range 19-25). All campers indicated that they would return to camp. Conclusion: Attending summer camp has a beneficial impact on emotional function, social function, self-esteem, and physical activity. Mean questionnaire scores from children with cardiac disease and cancer are similar to those of children with SCD. Increased funding should be awarded to sickle cell camps to allow for more children to have this beneficial experience.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA